Fourth Dimension Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6K Buy
323
+73
+29% +$4.19K 0.01% 393
2026
Q1
$15.2K Sell
250
-34
-12% -$1.98K 0.01% 365
2025
Q4
$15.3K Buy
284
+34
+14% +$1.64K 0.01% 365
2025
Q3
$11.3K Sell
250
-196
-44% -$9.15K ﹤0.01% 406
2025
Q2
$20.6K Sell
446
-200
-31% -$9.82K 0.01% 316
2025
Q1
$39.4K Sell
646
-200
-24% -$11.7K 0.02% 244
2024
Q4
$47.9K Buy
+846
New +$47.3K 0.03% 227

Other funds holding BMY

Fourth Dimension Wealth's BMY Position: Q2 2026 in Review

Fourth Dimension Wealth increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, buying an estimated $4.19K and bringing the position to 323 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #393.

Fourth Dimension Wealth first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.9K in Q4 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Fourth Dimension Wealth held 323 shares of Bristol-Myers Squibb worth $18.6K as of Q2 2026.
  • Fourth Dimension Wealth bought 73 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.19K.
  • Bristol-Myers Squibb made up 0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #393 holding.
  • Fourth Dimension Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Fourth Dimension Wealth's Bristol-Myers Squibb position peaked at $47.9K in Q4 2024.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.